Company news
Allergy Therapeutics plc news in 2026
Allergy Therapeutics plc's news releases, calls and decks from 2026, newest first.
Proposed Cancellation of Admission
November 3, 2026
Trading update for the year ended 30 June 2026
July 29, 2026
Appointment of Executive Chairman
July 28, 2026
Vesting of Options under Long-Term Incentive Plan
June 30, 2026
Long Term Incentive Awards
June 15, 2026
Allergy Therapeutics to present at EAACI 2026
June 12, 2026
Interim Results for six months ended 31 Dec 2025
March 31, 2026
PDMR Dealings & Shareholding Update
March 12, 2026
Positive Biomarker Results from PROTECT Trial
March 4, 2026
Allergy Therapeutics presents progress at AAAAI
February 26, 2026
Update on funding and total voting rights
February 23, 2026
Results of Annual General Meeting
February 2, 2026
Chief Strategy Officer and Board appointments
January 30, 2026
Result of Annual General Meeting
January 29, 2026
Grant of Options under Long Term Incentive Scheme
January 28, 2026
Half Year Trading Update
January 19, 2026
Notice of 2025 Annual General Meeting
January 6, 2026